Investors with a lot of money to spend have taken a bullish stance on Novo Nordisk (NYSE:NVO).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with NVO, it often means somebody knows something is about to happen.
So how do we know what these investors just did?
Today, Benzinga's options scanner spotted 11 uncommon options trades for Novo Nordisk.
This isn't normal.
The overall sentiment of these big-money traders is split between 63% bullish and 36%, bearish.
Out of all of the special options we uncovered, 3 are puts, for a total amount of $464,895, and 8 are calls, for a total amount of $2,906,247.
Expected Price Movements
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $75.0 to $130.0 for Novo Nordisk during the past quarter.
Analyzing Volume & Open Interest
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Novo Nordisk's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Novo Nordisk's whale activity within a strike price range from $75.0 to $130.0 in the last 30 days.
Novo Nordisk Call and Put Volume: 30-Day Overview
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVO | CALL | TRADE | BULLISH | 12/20/24 | $2.88 | $2.54 | $2.82 | $112.00 | $1.9M | 3.0K | 457 |
| NVO | CALL | SWEEP | BEARISH | 12/20/24 | $6.35 | $6.15 | $6.21 | $105.00 | $386.4K | 3.9K | 811 |
| NVO | PUT | TRADE | BULLISH | 12/20/24 | $2.75 | $2.6 | $2.61 | $105.00 | $261.0K | 14.3K | 1.9K |
| NVO | CALL | SWEEP | BULLISH | 06/20/25 | $5.1 | $5.05 | $5.1 | $130.00 | $208.5K | 405 | 0 |
| NVO | PUT | SWEEP | BEARISH | 06/20/25 | $5.3 | $4.9 | $4.9 | $95.00 | $176.4K | 1.7K | 360 |
About Novo Nordisk
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
After a thorough review of the options trading surrounding Novo Nordisk, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
Current Position of Novo Nordisk Trading volume stands at 1,381,254, with NVO's price up by 0.24%, positioned at $108.31. RSI indicators show the stock to be may be approaching overbought. Earnings announcement expected in 43 days.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Novo Nordisk, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
